SCHEMBL27435477

SCHEMBL27435477

COC(=O)c1c(OC)c(Cl)cc2c1OCCN2CCCc1nccs1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90B1 P14625 4/20 0.40
HSP90AA1 P07900 3/20 0.40
CYP3A4 P08684 2/20 0.34
GRM5 P41594 1/20 0.33
HTR2C P28335 2/20 0.33
HTR2B P41595 1/20 0.33
TSHR P16473 2/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32
DRD3 P35462 5/20 0.31
DRD2 P14416 3/20 0.31
DRD4 P21917 3/20 0.31
HTR1A P08908 1/20 0.31
HTR2A P28223 1/20 0.31
SPR P35270 1/20 0.31
DRD1 P21728 2/20 0.31
DRD5 P21918 2/20 0.31
MAPK1 P28482 1/20 0.31
SCN5A Q14524 1/20 0.30
SCN9A Q15858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27435494 0.92 GRM5 (0.33) HSP90B1HSP90AA1CYP3A4GRM5HTR2C
SCHEMBL30954078 0.92 GRM5 (0.33) HSP90B1HSP90AA1CYP3A4GRM5HTR2C
SCHEMBL27435439 0.89 HSP90B1 (0.44) HSP90B1HSP90AA1CYP3A4GRM5HTR2C
SCHEMBL27435450 0.81 CYP3A4 (0.38) HSP90B1HSP90AA1CYP3A4GRM5HTR2C
SCHEMBL30954041 0.81 CYP3A4 (0.38) HSP90B1HSP90AA1CYP3A4GRM5HTR2C
SCHEMBL27434914 0.79 TSHR (0.39) HSP90B1HSP90AA1TSHRDRD3MAPK1
SCHEMBL27435327 0.78 DRD2 (0.40) CYP3A4HTR2CCYP2D6CYP2C19DRD3
SCHEMBL27435364 0.77 KCNA3 (0.42) HTR2CTSHRDRD3DRD2DRD4
SCHEMBL30954135 0.77 POLB (0.44) HSP90B1HSP90AA1TSHRMAPK1
SCHEMBL27434651 0.77 TP53 (0.41) TSHRCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630412-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD Pharma A/S (DK) 2025-10-15 EP disclosed
WO-2024121130-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD PHARMA A/S (DK) 2024-06-13 WO disclosed
WO-2024121130-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD PHARMA A/S (DK) 2024-06-13 WO disclosed